PTCy and ATG for MSD and MUD Transplants

Conditions: Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Myelodysplastic Syndromes; Hodgkin Lymphoma; Non-hodgkin Lymphoma Interventions: Drug: ATG 5.0; Drug: Cyclophosphamide injection; Drug: ATG 2.5 ±1.5 Sponsors: Instituto Nacional de Cancer, Brazil Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials